RESUMO
Fabry disease (FD), which is a lysosomal storage disease resulting from a deficiency of α-galactosidase A, leads to the accumulation of globotriaosylceramide in various tissues and multiorgan impairment. Early diagnosis is important to improve long-term prognosis. Early clinical manifestations of FD include neuropathic pain, vascular skin lesions, and sweating abnormalities. Hypohidorosis is one of the clinical findings in the early stage of FD. However, there have been no studies on prospective screening of FD in patients with definitive diagnosis of hypohidrosis. We examined α-galactosidase A activity in white blood cells in 17 (one female and 16 male) patients with generalized hypohidorosis. Among 17 patients, one male patient (approximately 5.8%) had significantly reduced α-galactosidase A activity. He presented with a history of hypohidrosis with heat intolerance and neuropathic tingling pain in a warm environment from 6 years ago. He had a few angiokeratoma on the trunk and extremities. Ultrastructural examination of skin biopsy from the angiokeratoma revealed lamellar inclusions in endothelial cells. Kidney biopsy revealed swollen podocytes and Gb3 deposition in the glomerulus, and urinalysis revealed mulberry bodies. He was finally diagnosed with FD and started on enzyme replacement therapy with agalsidase alpha in the early stage. In addition, his family screening led to find the patients of four additional FD. Screening for FD in patients with hypohidrosis may lead to efficient early detection of FD.
Assuntos
Doença de Fabry , Hipo-Hidrose , Neoplasias Cutâneas , Células Endoteliais , Doença de Fabry/complicações , Doença de Fabry/diagnóstico , Feminino , Humanos , Hipo-Hidrose/diagnóstico , Masculino , Estudos Prospectivos , alfa-GalactosidaseRESUMO
PURPOSE: The aim of this study was to review the evidence on the epidemiology, physiopathology, categorization, and management of cholinergic urticaria. We specifically focused on several subtypes of cholinergic urticaria and investigated the relationship between cholinergic urticaria and idiopathic anhidrosis. METHODS: Using an integrative approach, we reviewed publications addressing the epidemiology, clinical features, diagnostic approach, physiopathology, subtype classification, and therapeutic approach to cholinergic urticaria. RESULTS: Multiple mechanisms were found to contribute to the development of cholinergic urticaria. This disorder should be classified based on the pathogenesis and clinical characteristics of each subtype. Such a classification system would lead to better management of this resistant condition. In particular, sweating function should be given more attention when examining patients with cholinergic urticaria. CONCLUSIONS: Because cholinergic urticaria is not a homogeneous disease, its subtype classification is essential for selection of the most suitable therapeutic method.
Assuntos
Sudorese/fisiologia , Urticária/etiologia , Urticária/fisiopatologia , Urticária/terapia , Temperatura Corporal , Temperatura Alta/efeitos adversos , HumanosAssuntos
Dermatose Linear Bolhosa por IgA/diagnóstico , Complicações na Gravidez/diagnóstico , Adulto , Anti-Infecciosos/uso terapêutico , Dapsona/uso terapêutico , Diagnóstico Diferencial , Quimioterapia Combinada , Feminino , Glucocorticoides/uso terapêutico , Humanos , Dermatose Linear Bolhosa por IgA/tratamento farmacológico , Prednisolona/uso terapêutico , Gravidez , Complicações na Gravidez/tratamento farmacológico , Terceiro Trimestre da GravidezAssuntos
Angioedema/diagnóstico , Angioedema/imunologia , Urticária/diagnóstico , Urticária/imunologia , Adolescente , Adulto , Angioedema/tratamento farmacológico , Angioedema/patologia , Ciclosporina/uso terapêutico , Pálpebras/imunologia , Feminino , Antagonistas dos Receptores Histamínicos H1/uso terapêutico , Antagonistas dos Receptores H2 da Histamina/uso terapêutico , Liberação de Histamina/imunologia , Humanos , Imunossupressores/uso terapêutico , Malassezia/imunologia , Pessoa de Meia-Idade , Cloridrato de Olopatadina/uso terapêutico , Estudos Retrospectivos , Testes Cutâneos , Urticária/tratamento farmacológico , Urticária/patologia , Adulto JovemAssuntos
Anafilaxia/induzido quimicamente , Hipersensibilidade a Drogas , Anafilaxia/terapia , Antibacterianos/efeitos adversos , Antibacterianos/química , Anti-Inflamatórios não Esteroides/efeitos adversos , Antineoplásicos/efeitos adversos , Meios de Contraste/efeitos adversos , Hipersensibilidade a Drogas/terapia , Humanos , Compostos de Iodo/efeitos adversosRESUMO
Anti-tumor necrosis factor (TNF)-α therapy is used for the treatment of psoriasis, with varying outcomes. However, the specific cause of inadequate response or treatment failure remains unknown. The aim of the present study was to identify useful clinical biomarkers for predicting therapeutic responses or to serve as new drug targets for refractory psoriasis cases. We performed a genome-wide association study (GWAS) of 65 psoriasis patients who were prospectively followed after beginning anti-TNF-α therapy using Human Omni Express-8 v1.2 Beadchips. Patients were enrolled at the dermatology departments of Kobe University Hospital and six collaborative hospitals. Associations between single nucleotide polymorphisms (SNP) and changes in the Psoriasis Area and Severity Index (PASI) after 12 weeks of treatment were evaluated. After genome data collection and quality control, a total of 731 442 SNPs were identified in 65 Asian psoriasis patients who were treated with adalimumab or infliximab. Here, we present 10 SNPs, such as those in JAG2 and ADRA2A, that were associated with treatment responses to anti-TNF-α agents (strongest effect, P < 7.11E-06). This is the first GWAS to examine SNP associated with treatment responses in psoriasis patients. In addition, we identified other SNP that exhibited potential associations with anti-TNF-α treatment response, which merit further study. Of these, rs11096957 on TLR10, which is associated with increased TNF-α production, was previously reported to be associated with treatment responses to TNF-α inhibitors.
Assuntos
Adalimumab/uso terapêutico , Antirreumáticos/uso terapêutico , Infliximab/uso terapêutico , Psoríase/tratamento farmacológico , Psoríase/genética , Adalimumab/farmacologia , Antirreumáticos/farmacologia , Feminino , Estudo de Associação Genômica Ampla , Humanos , Infliximab/farmacologia , Masculino , Pessoa de Meia-Idade , Polimorfismo de Nucleotídeo Único , Estudos Prospectivos , Fator de Necrose Tumoral alfa/antagonistas & inibidoresAssuntos
Acetamidas/uso terapêutico , Antagonistas dos Receptores Histamínicos H1/uso terapêutico , Antagonistas dos Receptores H2 da Histamina/uso terapêutico , Sistema Colinérgico não Neuronal , Piperidinas/uso terapêutico , Piridinas/uso terapêutico , Urticária/tratamento farmacológico , Adolescente , Adulto , Quimioterapia Combinada , Feminino , Humanos , Masculino , Qualidade de Vida , Urticária/etiologia , Adulto JovemRESUMO
Metal often causes delayed-type hypersensitivity reactions, which are possibly mediated by accumulating T cells in the inflamed skin, called irritant or allergic contact dermatitis. However, accumulating T cells during development of a metal allergy are poorly characterized because a suitable animal model is unavailable. We have previously established novel murine models of metal allergy and found accumulation of both metal-specific T cells and natural killer (NK) T cells in the inflamed skin. In our novel models of metal allergy, skin hypersensitivity responses were induced through repeated sensitizations by administration of metal chloride and lipopolysaccharide into the mouse groin followed by metal chloride challenge in the footpad. These models enabled us to investigate the precise mechanisms of the immune responses of metal allergy in the inflamed skin. In this review, we summarize the immune responses in several murine models of metal allergy and describe which antigen-specific responses occur in the inflamed skin during allergic contact dermatitis in terms of the T cell receptor. In addition, we consider the immune regulation of accumulated NK T cells in metal ion-induced allergic contact dermatitis.
Assuntos
Dermatite Alérgica de Contato/imunologia , Metais Pesados/farmacologia , Células T Matadoras Naturais/imunologia , Receptores de Antígenos de Linfócitos T/imunologia , Pele/imunologia , Animais , Movimento Celular/efeitos dos fármacos , Dermatite Alérgica de Contato/genética , Dermatite Alérgica de Contato/patologia , Modelos Animais de Doenças , Expressão Gênica , Virilha , Membro Posterior , Humanos , Injeções , Lipopolissacarídeos/farmacologia , Camundongos , Células T Matadoras Naturais/efeitos dos fármacos , Células T Matadoras Naturais/patologia , Receptores de Antígenos de Linfócitos T/genética , Pele/efeitos dos fármacos , Pele/patologiaRESUMO
Chromium (Cr) causes delayed-type hypersensitivity reactions possibly mediated by accumulating T cells into allergic inflamed skin, which are called irritants or allergic contact dermatitis. However, accumulating T cells during development of metal allergy are poorly characterized because a suitable animal model is not available. This study aimed to elucidate the skewing of T-cell receptor (TCR) repertoire and cytokine profiles in accumulated T cells in inflamed skin during elucidation of Cr allergy. A novel model of Cr allergy was induced by two sensitizations of Cr plus lipopolysaccharide solution into mouse groin followed by single Cr challenge into the footpad. TCR repertoires and nucleotide sequences of complementary determining region 3 were assessed in accumulated T cells from inflamed skin. Cytokine expression profiles and T-cell phenotypes were determined by qPCR. CD3+CD4+ T cells accumulated in allergic footpads and produced increased T helper 1 (Th1) type cytokines, Fas, and Fas ligand in the footpads after challenge, suggesting CD4+ Th1 cells locally expanded in response to Cr. Accumulated T cells included natural killer (NK) T cells and Cr-specific T cells with VA11-1/VB14-1 usage, suggesting metal-specific T cells driven by invariant NKT cells might contribute to the pathogenesis of Cr allergy.
Assuntos
Cromo , Dermatite Alérgica de Contato/imunologia , Modelos Animais de Doenças , Camundongos/imunologia , Receptores de Antígenos de Linfócitos T/imunologia , Pele/patologia , Linfócitos T/imunologia , Animais , Citocinas/imunologia , Dermatite Alérgica de Contato/etiologia , Dermatite Alérgica de Contato/patologia , Feminino , Camundongos Endogâmicos BALB C , Pele/imunologia , Linfócitos T/patologiaAssuntos
Diabetes Mellitus Tipo 2/complicações , Diabetes Mellitus Tipo 2/tratamento farmacológico , Psoríase/complicações , Glicemia/metabolismo , Diabetes Mellitus Tipo 2/sangue , Humanos , Hipoglicemiantes/uso terapêutico , Insulina/uso terapêutico , Masculino , Pessoa de Meia-Idade , Índice de Gravidade de DoençaRESUMO
Metal allergy is categorized as a delayed-type hypersensitivity reaction, and is characterized by the recruitment of lymphocytes into sites of allergic inflammation. Because of the unavailability of suitable animal models for metal allergy, the role of T cells in the pathogenesis of metal allergy has not been explored. Thus, we developed a novel mouse model for metal allergy associated with infiltration of T cells by multiple injections of palladium (Pd) plus lipopolysaccharide into the footpad. Using this model, we characterized footpad-infiltrating T cells in terms of phenotypic markers, T cell receptor (TCR) repertoires and cytokine expression. CD3+ CD4+ T cells accumulated in the allergic footpads 7 days after Pd challenge. The expression levels of CD25, interleukin-2, interferon-γ and tumor necrosis factor, but not interleukin-4 and interleukin-5, increased in the footpads after challenge, suggesting CD4+ T helper 1 (Th1) cells locally expanded in response to Pd. Infiltrated T cells in the footpads frequently expressed AV18-1 and BV8-2 T cell receptor (TCR) chains compared with T cells in the lymph nodes and exhibited oligoclonality. T-cell clones identified from Pd-allergic mouse footpads shared identical CDR3 sequences containing AV18-1 and BV8-2. These results suggest that TCR AV18-1 and BV8-2 play dominant and critical parts in the antigen specificity of Pd-specific Th1 cells.
Assuntos
Alérgenos/imunologia , Hipersensibilidade Tardia/imunologia , Hipersensibilidade Tardia/metabolismo , Paládio/efeitos adversos , Receptores de Antígenos de Linfócitos T/metabolismo , Células Th1/imunologia , Células Th1/metabolismo , Sequência de Aminoácidos , Animais , Biomarcadores/metabolismo , Regiões Determinantes de Complementaridade/química , Regiões Determinantes de Complementaridade/genética , Citocinas/genética , Citocinas/metabolismo , Modelos Animais de Doenças , Feminino , Hipersensibilidade Tardia/genética , Imuno-Histoquímica , Camundongos , Receptores de Antígenos de Linfócitos T/genética , Pele/imunologia , Pele/patologiaRESUMO
Nickel (Ni) can cause delayed-type hypersensitivity reactions, which are thought to be mediated by the accumulation of T cells into inflamed skin. Accumulated T cells at the developmental stages in metal allergy are poorly characterized because a suitable animal model has not been established. To investigate the accumulated T cells in allergic inflamed skin, we generated a novel murine model of Ni-induced allergy. The murine model of Ni allergy was induced by two sensitizations of Ni plus lipopolysaccharide solution into the groin followed by three challenges with Ni solution into the footpad. Here we show that a specific TCR repertoire bearing Vα14Jα18, called natural killer (NK) T cells, was expanded monoclonally in BALB/c or C57BL/6 mice. Accumulation of NKT cells was characterized as CD4(+) or CD4(-)CD8(-) T cells. These results suggested that NKT cells are major pathogenic T cells at the elicitation phase of Ni allergy.
Assuntos
Hipersensibilidade Tardia/imunologia , Células T Matadoras Naturais/imunologia , Níquel/toxicidade , Receptores de Antígenos de Linfócitos T alfa-beta/imunologia , Dermatopatias Eczematosas/imunologia , Animais , Modelos Animais de Doenças , Hipersensibilidade Tardia/induzido quimicamente , Hipersensibilidade Tardia/genética , Imuno-Histoquímica , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C57BL , Células T Matadoras Naturais/efeitos dos fármacos , Níquel/imunologia , RNA Mensageiro/química , RNA Mensageiro/genética , Receptores de Antígenos de Linfócitos T alfa-beta/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Dermatopatias Eczematosas/induzido quimicamente , Dermatopatias Eczematosas/genéticaRESUMO
BACKGROUND: Challenge testing with wheat plus exercise and/or aspirin is a gold standard for the diagnosis of wheat-dependent exercise-induced anaphylaxis (WDEIA); however, the test may often yield false-negative results. Our previous study suggested that an increase in serum wheat gliadin levels is required to induce allergic symptoms in patients with WDEIA. Based on this knowledge, we sought to extract the patients with false negative results in the challenge tests of WDEIA. METHODS: Thirty-six patients with suspected WDEIA were enrolled. First, group categorizations-Group I, challenge tests were positive; Group II, challenge tests were negative and serum gliadin were undetectable; Group III, challenge tests were negative and serum gliadin were detectable-were given according to the results of wheat plus exercise and/or aspirin challenge testing and serum gliadin levels. Second, diagnoses were made using retests and/or dietary management in Group II and III. RESULTS: Positive results for wheat plus exercise and/or aspirin challenge tests gave a diagnosis of definite WDEIA in 17 of 36 patients (Group I). Of the remaining 19 challenge negative patients, serum gliadin was undetectable in ten patients (Group II). Of the ten patients (Group II), three of them were diagnosed as definite WDEIA by retesting and six of them were diagnosed as probable WDEIA using a wheat elimination diet, whereas one patient was non-WDEIA. In the rest of the nine challenge negative patients, serum gliadin was detectable (Group III). No allergic episodes with a normal diet provided a diagnosis of non-WDEIA in seven of the nine patients, whereas the remaining two patients were probable WDEIA or had another food allergy because of repeated episodes. CONCLUSIONS: Our study revealed that serum gliadin monitoring during challenge testing is useful.
Assuntos
Anafilaxia/diagnóstico , Anafilaxia/etiologia , Exercício Físico , Gliadina/sangue , Hipersensibilidade a Trigo/diagnóstico , Alérgenos/imunologia , Anafilaxia/prevenção & controle , Reações Falso-Negativas , Feminino , Hipersensibilidade Alimentar , Humanos , Masculino , Triticum/imunologia , Hipersensibilidade a Trigo/etiologia , Hipersensibilidade a Trigo/prevenção & controleRESUMO
Lichen planus pemphigoides (LPP) is a rare clinical variant of bullous pemphigoid (BP). A 35-year-old female patient presented to our hospital complaining of pruritic violaceous-colored plaques or papules on the extremities. Tense vesicles were also seen on the soles. Skin biopsies from the papules and vesicles demonstrated lichen planus and BP, respectively. Direct immunofluorescence demonstrated linear IgG and C3 deposition on the basement membrane zone. Indirect immunofluorescence on 1 M NaCl split skin detected IgG reactivity with the epidermal side. Enzyme-linked immunosorbent assay also detected anti-BP180 antibodies. After treatment with oral prednisolone alone had failed, low-dose cyclosporine A (CyA) was added. The clinical symptoms immediately improved and the titer of the anti-BP180 antibodies decreased. Although there is little information about the treatment of recalcitrant LPP, additional CyA appeared to be beneficial.
Assuntos
Carbocisteína/efeitos adversos , Febre/induzido quimicamente , Idoso , Carbocisteína/administração & dosagem , Carbocisteína/metabolismo , Ritmo Circadiano , Esquema de Medicação , Expectorantes/administração & dosagem , Expectorantes/efeitos adversos , Expectorantes/metabolismo , Feminino , Febre/metabolismo , Humanos , Testes do EmplastroRESUMO
Food-dependent exercise-induced anaphylaxis (FDEIA) is a severe systemic syndrome induced by physical exercise after ingesting causative food. Aspirin is a well-known trigger for anaphylaxis in patients with FDEIA. Possible mechanisms by which symptoms are aggravated by aspirin include enhanced antigen absorption and mast cell activation. The aim of this study was to determine whether aspirin intake has an influence on mast cell/basophil activation in patients with FDEIA. Provocation tests revealed that adding aspirin to the causative food challenge in 7 of 9 (77.8%) patients with FDEIA provoked symptoms. In most cases, pretreatment with aspirin did not enhance skin tests (71.4%) or histamine release tests (88.9%) with food allergen challenges. The study confirms that histamine release and skin prick tests can be adjunctive tools for diagnosing FDEIA. In addition, our results suggest that exacerbation of FDEIA symptoms by aspirin is not mediated by direct effects of aspirin on mast cell/basophil activation.
Assuntos
Anafilaxia/diagnóstico , Aspirina/efeitos adversos , Ensaio de Imunoadsorção Enzimática , Teste de Esforço , Exercício Físico , Hipersensibilidade Alimentar/diagnóstico , Liberação de Histamina/efeitos dos fármacos , Mastócitos/efeitos dos fármacos , Testes Cutâneos , Adolescente , Adulto , Idoso , Anafilaxia/imunologia , Basófilos/efeitos dos fármacos , Basófilos/imunologia , Feminino , Hipersensibilidade Alimentar/imunologia , Humanos , Masculino , Mastócitos/imunologia , Pessoa de Meia-Idade , Valor Preditivo dos Testes , Fatores de RiscoRESUMO
The patient is a 71-year-old male who has been suffering from rheumatoid arthritis for over 20 years. He first noticed the erythema on his right forearm in 2008, which got worse in 2009. Topical corticosteroids were not effective, and a skin biopsy was performed. Histopathologic examination showed aggregation of the inflammatory cells in the dermal vessels. Those cells were positive for CD68 and CD31 and all the surrounding vessels expressed D2-40 and CD31. We diagnosed him with intralymphatic histiocytosis. One week after the skin was biopsied, only the part of the erythematous lesion covered by skin tape had improved, suggesting that pressure on the lesion might improve the erythematous eruption. We therefore used a pressure bandage elbow supporter in addition to topical treatment. The lesion improved 3 months later and was totally diminished after 9 months. Combined with previously reported cases, our case suggested that intralymphatic histiocytosis is closely related to lymphostasis.